ESC 365 - Endpoint selection: who benefits from "net clinical benefit"?

ESC Premium Access

Endpoint selection: who benefits from "net clinical benefit"?

Session: Designing a clinical study - Learning from the masters

Topic: Trial Design

Speaker: Professor D. Francis (London, GB)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Darrel Francis

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

3 more presentations in this session

Superiority versus non-inferiority trials: the right answer for the appropriate question

Speaker: Professor R. Collins (Oxford, GB)

Changing the paradigm: registry-based randomized trials

Speaker: Professor S. James (Uppsala, SE)

Mendelian randomization: back to basics

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Access the full session

Designing a clinical study - Learning from the masters

Speakers: Professor D. Francis, Professor R. Collins, Professor S. James, Professor B. Nordestgaard

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources